Edwards Lifesciences
837 hedge funds and large institutions have $25.5B invested in Edwards Lifesciences in 2018 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 286 increasing their positions, 313 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
837
Holders Change
+23
Holders Change %
+2.83%
% of All Funds
19.19%
Holding in Top 10
22
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+4.76%
% of All Funds
0.5%
New
82
Increased
286
Reduced
313
Closed
54
Calls
$152M
Puts
$136M
Net Calls
+$15.6M
Net Calls Change
-$6.4M
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$269M |
| 2 |
2
Ameriprise
Minneapolis,
Minnesota
|
$340M |
| 3 |
3
Renaissance Technologies
New York
|
$72M |
| 4 |
4
Two Sigma Advisers
New York
|
$36.1M |
| 5 |
5
Bank of New York Mellon
New York
|
$1.09B |
